Logo

IonGate Raises $1.4M to Expand US Business

Sep 17, 2008
NEW YORK (GenomeWeb News) – IonGate Biosciences said today that it has raised €1 million ($1.4 million) in a new round of private funding from Hessen Kapital I.
 
The Frankfurt, Germany-based firm said that it would use the funds to expand its business in the US and increase global commercialization of its SURFE2R technology. IonGate recently launched its SURFE2R Workstation 5000 for functional screening of transporters in higher-throughput pharmaceutical discovery and development.
 
Earlier this year, IonGate raised €4.6 million ($6.8 million) in a third round of private financing with investors Heidelberg Innovation and Kreditanstalt für Wiederaufbau. The firm also established a New York-based subsidiary to help marketing efforts for the SURFE2R platform.
 

Breaking News
The Scan

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.